[
  {
    "ts": null,
    "headline": "Is Amgen Riding the Momentum After a 6.9% Price Jump?",
    "summary": "If you're looking at Amgen and wondering whether it's time to buy, hold, or maybe even take profits, you're not alone. The stock has had its fair share of ups and downs lately, and investors are keeping a close eye on where it might go next. In the past month, we have seen Amgen’s price climb an impressive 6.9%, even after a modest dip of 2.4% last week. Year to date, the stock is up 12.5%, which suggests optimism is returning. Yet, the longer-term one-year return is still down 4.9%. When you...",
    "url": "https://finnhub.io/api/news?id=6d4e26a2cd36f0ae9aa3ba41cb989fe7ca9c19186211528cca151b0385455c97",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761455424,
      "headline": "Is Amgen Riding the Momentum After a 6.9% Price Jump?",
      "id": 137216495,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "If you're looking at Amgen and wondering whether it's time to buy, hold, or maybe even take profits, you're not alone. The stock has had its fair share of ups and downs lately, and investors are keeping a close eye on where it might go next. In the past month, we have seen Amgen’s price climb an impressive 6.9%, even after a modest dip of 2.4% last week. Year to date, the stock is up 12.5%, which suggests optimism is returning. Yet, the longer-term one-year return is still down 4.9%. When you...",
      "url": "https://finnhub.io/api/news?id=6d4e26a2cd36f0ae9aa3ba41cb989fe7ca9c19186211528cca151b0385455c97"
    }
  }
]